Lays Sciences

Lay Sciences is a private biotechnology company based in Florida developing and commercializing oral IgY polyclonal antibody products for prophylaxis and treatment. Its platform uses proprietary formulations designed to protect avian IgY antibodies from gastric acid and proteases and release them in targeted regions of the gastrointestinal tract, with the goal of enabling local activity while limiting systemic exposure. The company has described ImmunIgY as its flagship product and indicated launches in select markets for COVID-19. Lay Sciences has also announced licensing relationships with partner companies for IgY and diagnostic assets and has discussed strategic partnering around gastrointestinal and upper respiratory indications. Overall, the company appears to be an early commercial-stage, platform-oriented biotech focused on oral antibody products for infectious disease and GI applications.